Blair William & CO Neuronetics, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Neuronetics, Inc. stock. As of the latest transaction made, Blair William & CO holds 10,252 shares of STIM stock, worth $14,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,252

Previous 10,589 3.18%

Holding current value

$14,147

Previous $19,000 63.16%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.73 - $2.0 $246 - $674	-337 Reduced 3.18%	10,252 $7,000
Q2 2024 Aug 12, 2024	BUY	$1.73 - $4.81 $18,318 - $50,933	10,589 New	10,589 $19,000
Q4 2023 Feb 12, 2024	SELL	$1.05 - $2.9 $83,818 - $231,498	-79,827 Reduced 87.52%	11,379 $32,000
Q3 2023 Nov 09, 2023	SELL	$1.29 - $2.22 $14,303 - $24,615	-11,088 Reduced 10.84%	91,206 $123,000
Q2 2023 Aug 11, 2023	SELL	$2.07 - $2.92 $114,733 - $161,846	-55,427 Reduced 35.14%	102,294 $219,000
Q1 2023 May 12, 2023	SELL	$2.81 - $6.71 $44,327 - $105,850	-15,775 Reduced 9.09%	157,721 $458,000
Q4 2022 Feb 10, 2023	SELL	$2.74 - $6.87 $1,509 - $3,785	-551 Reduced 0.32%	173,496 $1.19 Million
Q3 2022 Nov 09, 2022	BUY	$2.35 - $4.66 $17,406 - $34,516	7,407 Added 4.44%	174,047 $553,000
Q2 2022 Aug 10, 2022	SELL	$2.09 - $3.71 $56,603 - $100,477	-27,083 Reduced 13.98%	166,640 $535,000
Q1 2022 May 13, 2022	BUY	$2.84 - $4.52 $60,029 - $95,539	21,137 Added 12.25%	193,723 $587,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $54,439 - $92,701	14,067 Added 8.87%	172,586 $770,000
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $19,667 - $49,137	3,162 Added 2.04%	158,519 $1.04 Million
Q2 2021 Aug 12, 2021	BUY	$10.15 - $17.25 $53,206 - $90,424	5,242 Added 3.49%	155,357 $2.49 Million
Q1 2021 May 13, 2021	BUY	$10.6 - $21.27 $50,668 - $101,670	4,780 Added 3.29%	150,115 $1.86 Million
Q4 2020 Feb 09, 2021	BUY	$4.95 - $11.45 $8,251 - $19,087	1,667 Added 1.16%	145,335 $1.62 Million
Q3 2020 Nov 06, 2020	BUY	$1.82 - $5.87 $14,678 - $47,341	8,065 Added 5.95%	143,668 $698,000
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.61 $31,626 - $58,542	-22,430 Reduced 14.19%	135,603 $262,000
Q1 2020 May 11, 2020	BUY	$1.28 - $4.5 $83,328 - $292,950	65,100 Added 70.05%	158,033 $299,000
Q4 2019 Feb 13, 2020	SELL	$4.03 - $9.22 $211,836 - $484,649	-52,565 Reduced 36.13%	92,933 $417,000
Q3 2019 Nov 12, 2019	BUY	$8.31 - $13.03 $367,426 - $576,121	44,215 Added 43.65%	145,498 $1.21 Million
Q2 2019 Aug 13, 2019	SELL	$9.0 - $17.2 $212,265 - $405,662	-23,585 Reduced 18.89%	101,283 $1.27 Million
Q1 2019 May 14, 2019	SELL	$13.6 - $19.58 $22,467 - $32,346	-1,652 Reduced 1.31%	124,868 $1.9 Million
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $2.02 Million - $4.03 Million	126,520 New	126,520 $2.45 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

13.1M

Call Options Held

30.1K

Put Options Held

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $37.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account